TWO EMPLOYEES RESIGN AFTER PARTICIPATING IN A SCHEME TO SELL MISBRANDED AND UNAPPROVED NEW DRUGS

An Amtrak Electronic Specialist and a Maintainer based in Newark, New Jersey, resigned in lieu of their disciplinary hearings on September 14, 2022, and September 27, 2022, respectively. We determined that Keith Kovaleski, an Assistant Foreman based in New York who is currently awaiting sentencing after pleading guilty on March 21, 2022, to conspiring to distribute misbranded and unapproved new drugs, paid the two former employees to set up financial accounts to accept payments on behalf of Kovaleski for his illegal activities in exchange for a portion of the proceeds. In addition, the Maintainer received packages at his home for Kovaleski that contained misbranded and/or unapproved new drugs from Kovaleski’s company, All American Peptide (AAP). The Electronic Specialist ordered and received misbranded and/or unapproved new drugs from AAP at his home. The former employees are ineligible for rehire.